Target intelligence / Profile preview

Blood volume

Molecular classification
Physiological parameter
01

Overview

Blood volume refers to the total amount of circulating fluid within the vascular system at any given time. It consists primarily of plasma and cellular elements such as red cells. Blood volume is tightly regulated through neural mechanisms (autonomic nervous system), hormonal pathways—most notably the renin–angiotensin–aldosterone system and antidiuretic hormone—and renal excretion/reabsorption processes that control both water and electrolyte balance. The kidneys play a central role in adjusting plasma composition via glomerular filtration rate changes, sodium reabsorption/excretion, and erythropoietin-mediated regulation of red cell mass ("critmeter" function). Blood pressure sensors such as baroreceptors provide feedback on effective circulating blood flow rather than direct measurement; thus most regulatory systems respond to changes in perfusion rather than absolute intravascular fluid content. Disruptions in these regulatory systems can lead to clinical conditions including hypovolemia/shock or hypervolemic states like edema.

Other names
Circulating blood volumeIntravascular volumePlasma volumeWhole blood volume
02

Mechanism of action

Not applicable for "blood volume" as it is not a drug target. Mechanisms relate to modulation of renal handling of sodium/water or hormonal regulation: - Inhibition/stimulation of renal tubular transporters for Na+/water - Modulation of RAAS pathway components - Antidiuretic hormone action on kidney collecting ducts

03

Biological functions

Maintenance of tissue perfusionRegulation of blood pressureHomeostasis of fluid and electrolyte balanceOxygen and nutrient delivery to tissues
04

Disease associations

Cardiovascular disease (e.g., heart failure, hypertension)Shock (hypovolemic shock from low blood volume)Edema and fluid overload statesAnemia/polycythemia as related to red cell mass component
05

Safety considerations

Hypovolemia/dehydration with excessive diuresis or bleedingHypervolemia/fluid overload with excessive IV fluids or heart/kidney failure risk
06

Interacting drugs

Diuretics (e.g., furosemide)

4 more in the full profile.

07

Biomarkers

Hematocrit/red cell mass measurementPlasma osmolality/sodium concentrationCentral venous pressure/pulmonary capillary wedge pressure in clinical settings

Beyond the preview

Go deeper on Blood volume.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood volume.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call